Research Article
Is Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?
Table 4
Diagnostic performance of the criteria evaluated.
| | | Sensitivity % | Specificity % | PPV (%) | NPV (%) | +ve likelihood ratio | −ve likelihood ratio |
| | RMI ≥ 250 | 54.05 (20/37) | 93.4 (228/244) | 55.5 (20/36) | 93.06 (228/245) | 8.1 | 0.49 | | CA125 ≥ 35 | 70.2 (26/37) | 67.6 (165/244) | 24.7 (26/105) | 93.7 (165/176) | 2.1 | 0.44 | | Ultrasound score 3 | 78.3 (29/37) | 81.5 (199/244) | 39.1 (29/74) | 96.1 (199/207) | 4.2 | 0.26 | | Menopause score 3 | 51.3 (19/37) | 85.6 (209/244) | 35.1 (19/54) | 92.0 (209/227) | 3.5 | 0.56 |
|
|
